DAVID CHANG: Open Payments
NPI 1487638581 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 91 payments from 22 companies in 2025. Trend: 2023 $1,772 · 2024 $1,921 · 2025 $1,553
Food & beverage: $1,553
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $227 |
| ABBVIE INC. | 13 | $176 |
| PFIZER INC. | 9 | $174 |
| Novo Nordisk Inc | 12 | $166 |
| Lilly USA, LLC | 12 | $149 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Esperion Therapeutics, Inc. | 4 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Exact Sciences Corporation | 3 | $47 |
Products named: FARXIGA, LEQVIO, MOUNJARO, ELIQUIS, Ozempic, UBRELVY, XIFAXAN, NEXLETOL.
Industry payments across SC — which companies pay providers there.
